The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Impact of adjuvant chemotherapy with 5-FU or FOLFOX in colon cancers with microsatellite instability: An AGEO multicenter study.
David Tougeron
No relevant relationships to disclose
Gaelle Sickersen
No relevant relationships to disclose
Thierry Lecomte
No relevant relationships to disclose
Guillaume Mouillet
No relevant relationships to disclose
Isabelle Trouilloud
No relevant relationships to disclose
Romain Coriat
No relevant relationships to disclose
Thomas Aparicio
No relevant relationships to disclose
Gaetan Des Guetz
No relevant relationships to disclose
Cedric Lecaille
No relevant relationships to disclose
Pascal Artru
No relevant relationships to disclose
Estelle Cauchin
No relevant relationships to disclose
David Sefrioui
No relevant relationships to disclose
Tarek Boussaha
No relevant relationships to disclose
Aurelie Ferru
No relevant relationships to disclose
Julien Taïeb
No relevant relationships to disclose
Pierre Michel
No relevant relationships to disclose
Lucie Karayan-Tapon
No relevant relationships to disclose
Dewi Vernerey
No relevant relationships to disclose
Franck Bonnetain
No relevant relationships to disclose
Aziz Zaanan
No relevant relationships to disclose